[{"data":1,"prerenderedAt":182},["ShallowReactive",2],{"drug-acarbose":3},{"id":4,"schemaVersion":5,"name":6,"category":9,"class":10,"brands":13,"synonyms":20,"formulations":24,"regimens":55,"contraindications":83,"warnings":93,"renal":94,"monitoring":95,"interactions":96,"review":97,"examples":100,"atc":106,"iran":108,"links":124,"populations":141,"usApproval":177},"acarbose",1,{"fa":7,"en":8},"آکاربوز","Acarbose","alimentary-metabolism",{"fa":11,"en":12},"مهارکننده آلفا-گلوکوزیداز","Alpha-glucosidase inhibitor",[14,17],{"name":15,"market":16},"Precose","US",{"name":18,"market":19},"Glucobay","GB",[21,22,23,7],"glucobay","precose","گلوکوبای",[25,39,47],{"id":26,"form":27,"route":28,"label":29,"concentration":30,"markets":34,"refs":35},"tab-25","tablet","oral","25 mg tablet",{"amount":31,"unit":32,"perUnit":27,"scored":33},25,"mg",false,[16],[36],{"source":37,"section":38},"fda-acarbose","How Supplied",{"id":40,"form":27,"route":28,"label":41,"concentration":42,"markets":44,"refs":45},"tab-50","50 mg tablet",{"amount":43,"unit":32,"perUnit":27,"scored":33},50,[16],[46],{"source":37,"section":38},{"id":48,"form":27,"route":28,"label":49,"concentration":50,"markets":52,"refs":53},"tab-100","100 mg tablet",{"amount":51,"unit":32,"perUnit":27,"scored":33},100,[16],[54],{"source":37,"section":38},[56],{"id":57,"disease":58,"label":59,"population":62,"type":66,"unit":32,"dose":67,"refs":69,"limits":72,"notes":76},"t2","type-2-diabetes",{"fa":60,"en":61},"دیابت نوع ۲ — شروع ۲۵ mg سه بار در روز با اولین لقمه","Type 2 diabetes — start 25 mg three times daily with the first bite",{"minAge":63},{"value":64,"unit":65},18,"year","fixed",{"perDose":31,"dosesPerDay":68},3,[70],{"source":37,"section":71},"Dosage and Administration",{"maxPerDay":73,"refs":74},300,[75],{"source":37,"section":71},[77],{"text":78,"refs":81},{"fa":79,"en":80},"حداکثر: تا ۶۰ kg ← ۵۰ mg سه بار؛ بالای ۶۰ kg ← ۱۰۰ mg سه بار.","Maximum: ≤60 kg → 50 mg three times daily; >60 kg → 100 mg three times daily.",[82],{"source":37,"section":71},[84],{"id":85,"severity":86,"text":87,"refs":90},"ci","block",{"fa":88,"en":89},"کتواسیدوز دیابتی؛ سیروز؛ بیماری التهابی روده، زخم کولون، انسداد نسبی روده؛ حساسیت.","Diabetic ketoacidosis; cirrhosis; inflammatory bowel disease, colonic ulceration, partial obstruction; hypersensitivity.",[91],{"source":37,"section":92},"Contraindications",[],[],[],[],{"status":98,"reviewer":99,"date":99},"unverified",null,[101],{"regimen":57,"formulation":26,"input":102,"expect":105},{"ageYears":103,"weightKg":104},55,80,{"perDose":31,"tabletsPerDoseRounded":5},[107],"A10BF01",{"status":109,"forms":110,"refs":119},"registered",[111,115],{"code":112,"en":113,"fa":114},"02015","ACARBOSE 100MG TAB","قرص آکاربوس ۱۰۰ میلی‌گرم",{"code":116,"en":117,"fa":118},"02016","ACARBOSE 50MG TAB","قرص آکاربوس ۵۰ میلی‌گرم",[120],{"source":121,"section":122,"url":123},"darooyab-generic","G-619\u002FAcarbose","https:\u002F\u002Fwww.darooyab.ir\u002FG-619\u002FAcarbose",[125,129,133,136,139],{"kind":126,"url":127,"label":128},"fda","https:\u002F\u002Fwww.accessdata.fda.gov\u002Fscripts\u002Fcder\u002Fdaf\u002Findex.cfm?event=overview.process&ApplNo=090912","ANDA090912",{"kind":130,"url":131,"label":132},"dailymed","https:\u002F\u002Fdailymed.nlm.nih.gov\u002Fdailymed\u002FdrugInfo.cfm?setid=656769ee-e292-4950-83df-a38e6b1a9d6e","FDA Acarbose",{"kind":134,"url":135,"label":8},"medlineplus","https:\u002F\u002Fmedlineplus.gov\u002Fdruginfo\u002Fmeds\u002Fa696015.html",{"kind":137,"url":138,"label":107},"who-atc","https:\u002F\u002Fatcddd.fhi.no\u002Fatc_ddd_index\u002F?code=A10BF01",{"kind":140,"url":123,"label":8},"darooyab",{"pregnancy":142,"lactation":151,"pediatric":159,"geriatric":168},{"level":143,"text":144,"quote":147,"refs":148},"caution",{"fa":145,"en":146},"برچسب خطر مشخصی برای بارداری ذکر نکرده یا داده کافی ندارد؛ فقط در صورت لزوم و با نظر پزشک.","Label states no clear risk or has limited data; use only if needed, under medical advice.","Teratogenic Effects: Pregnancy Category B.",[149],{"source":37,"section":150},"PREGNANCY",{"level":143,"text":152,"quote":155,"refs":156},{"fa":153,"en":154},"برچسب: در شیردهی با احتیاط؛ متن برچسب را ببینید.","Label: use with caution while breastfeeding; see the label text.","A small amount of radioactivity has been found in the milk of lactating rats after administration of radiolabeled acarbose.",[157],{"source":37,"section":158},"Precautions\u002FWarnings – Nursing Mothers",{"level":160,"text":161,"quote":164,"refs":165},"not-established",{"fa":162,"en":163},"برچسب: ایمنی و اثربخشی در کودکان ثابت نشده است.","Label: safety and effectiveness in children have not been established.","Safety and effectiveness of Acarbose Tablets in pediatric patients have not been established.",[166],{"source":37,"section":167},"Precautions\u002FWarnings – Pediatric Use",{"level":169,"text":170,"quote":173,"refs":174},"ok",{"fa":171,"en":172},"برچسب: در سالمندان تفاوت یا تنظیم دوز خاصی ذکر نشده.","Label: no specific difference or dose adjustment stated for older adults.","No overall differences in safety and effectiveness were observed between these subjects and younger subjects.",[175],{"source":37,"section":176},"Precautions\u002FWarnings – Geriatric Use",{"kind":178,"refs":179,"id":128},"ANDA",[180],{"source":37,"section":181},"SPL approval \u002F marketing category",1792092020447]